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Abstract 
BACKGROUND: Platelet-rich plasma (PRP) is an autologous concentration of platelets that contain a large 
number of growth factors. These growth factors play a role in the regeneration, repair, and acceleration of the 
biochemical process, thereby reducing the pain associated with injuries of the articular cartilage and meniscus 
AIM: The purpose of this study is to evaluate the effect of the PRP method in the treatment of knee joint cartilage 
injuries and degenerative meniscus lesions as well as pain relief. 
MATERIAL AND METHODS: The process of obtaining PRP begins by taking 15 ml of blood from the patient with 
a special system called Arthrex Double Syringe system. The test tube is centrifuged at 4000 rpm for 5 minutes. 
From the separated plasma, 5-6 ml PRP is taken and prepared for application. PRP is administered intra-
articularly. 
RESULTS: At the Jan Mitrev Clinic in Skopje in 2018, PRP procedures were performed on 126 patients, 56 
(44.4%) of whom were male, and 70 (55.6%) were female. The patients were evaluated by the Tegner Lysholm 
Knee Scoring Scale (TLKSS) before applying 3 doses of PRP for 7 days as well as 3 and 6 months after the 
application of PRP. The results showed considerable improvement 3 months after the PRP application, and 6 
months after the application the results remained approximately identical.  
CONCLUSION: The application of PRP in the field of medicine is widely applied, and it will continue to be 
because the understanding of PRP therapy is increasingly refined. This therapy represents a potential and latest 
method in short-term pain reduction, but additional studies are needed to prove its long-term effectiveness. 
 
 
 
 
 
Introduction 
 
The most recent research and findings in the 
treatment of knee pain in articular cartilage injuries 
and degenerative meniscus lesions are increasing the 
need for biology and its association with the 
inflammatory process. The normal function and 
preservation of articular cartilage and meniscus 
morphology depend primarily on the balance between 
aggressive and protective factors [1]. Biology and its 
use are extremely important for the balance between 
these factors [2], [3], [4]. Platelet-rich plasma (PRP) is 
increasingly used in articular cartilage injuries and 
degenerative meniscus lesions. PRP is an autologous 
concentration of platelets that contain a large number 
of growth factors [5], [6], [7], [8]. These growth factors 
play a role in the regeneration, repair, and 
acceleration of biochemical processes, thereby 
reducing the pain associated with injuries of the 
articular cartilage and meniscus [9]. The latest world 
research shows excellent results in reducing pain by 
using PRP [10], [11], [12], [13], [14]. In the Republic of 
Macedonia, the PRP application has been used for 
the last decade. 
The purpose of this study is to evaluate the 
effect of the PRP method in the treatment of knee joint 
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cartilage injuries and degenerative meniscus lesions 
as well as pain relief. 
Material and Methods 
 
A prospective six-month study involved 15 
patients treated at the Zan Mitrev Clinic in Skopje in 
2018. All patients underwent a clinical examination, X-
ray examinations and magnetic resonance imaging of 
the knee. They all received 3 doses of PRP applied 
over 7 days.  
 
Figure 1: Taking 15 ml blood sample 
 
 The process of obtaining PRP begins by 
taking 15 ml of blood from the patient (Figure 1) with a 
special system called Arthrex Double Syringe system 
(Figure 2). 
 
Figure 2: Arthrex Double Syringe System 
 
The test tube is centrifuged at 4000 rpm for 5 
minutes (Figure 3).  
 
Figure 3: Centrifuge at 4000 rpm 
 
 From the separated plasma, 5-6 ml PRP is 
taken and prepared for application (Figure 4). PRP is 
administered intra-articularly (Figure 5). The Tegner 
Lysholm Knee Scoring Scale was used for evaluating 
the patients at the first and sixth month after the 
treatment with PRP.  
 
Figure 4: PRP ready for application 
 
 All patients included in the study signed a 
consent to participate in the study, as well as consent 
for publishing the results. 
 
Figure 5: Intra-articular application of PRP 
 
Statistical method 
The statistical series, according to the defined 
variables of interest, are tabulated and graphically 
presented. The distribution of the numerical statistical 
series (correct/incorrect) was tested with Kolmogorov 
Smirnov test, Lilliefors test and Shapiro-Wilk’s W test. 
The numerical series structure was analysed with the 
central tendency (mean) and dispersion measures 
(standard deviation). The significance test of the 
difference between two arithmetic means in the 
independent samples was performed with the 
parametric Student-t-test. The significance test of the 
difference between the two-arithmetic means in the 
dependent samples was performed with the 
nonparametric Wilcoxon matched-pairs test.  
Testing the significance of the differences 
between the three arithmetic meanings in the 
dependent samples was performed with Friedman 
ANOVA, the significance level for p < 0.05 at Cl = 
95% is considered statistically significant. The 
database is analysed with the statistical program 
STATISTICA 12 for Windows. 
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Results 
 
At the Zan Mitrev Clinic in Skopje in 2018, 
PRP procedures were performed on 126 patients, 56 
(44.4%) of whom were male, and 70 (55.6%) were 
female. From the 126 patients, 15 were examined and 
evaluated in this study, 10 of them (66.7%) were 
female, and 5 (33.3%) were male. The average age of 
the total number of respondents was 49.3 ± 6.3 years.  
Table 1: Mean Age Value of Examined Patients by Sex 
Sex Mean Std. Dev. Min Max 
Females 49.1 5.8 38 60 
Males 49.8 7.8 36 55 
Total 49.3 6.3 36 60 
 
 The average age of the female respondents 
was 49.1 ± 5.8, and for males, it was 49.8 ± 7.8 years. 
There was no significant difference in age between 
the subjects of both sexes (There was no significant 
difference in age between the subjects of both sexes 
(Student-t-test: t = - 0.196, p = 0.8475) (Table 1 and 
Figure 6). 
 
Figure 6: Mean Age Value of Examined Patients by Sex 
 
The patients were evaluated by the TLKSS 
(Tegner Lysholm Knee Scoring Scale) before applying 
3 doses of PRP for 7 days as well as 3 and 6 months 
after the application of PRP. The results showed 
considerable improvement 3 months after the PRP 
application, and 6 months after the application the 
results remained approximately identical.  
The mean value of TLKSS before the 
intervention was 61.9 ± 7.4 after 3 months, and after 6 
months, it was 83.4 ± 4.6 and 83.4 ± 4.3, respectively. 
The variance analysis showed that there were 
statistically significant differences concerning the 
TLKSS at the three points of time (Friedman ANOVA: 
Chi. Sqr. = 24.54, p = 0.00001). There also was a 
statistically significant difference between the mean 
values of TLKSS before the intervention and after 3 
months (Wilcoxon matched-pairs test: Z = 3.407, p = 
0.00062). There was also a statistically significant 
difference between the mean values of TLKSS before 
the intervention and 6 months after (Wilcoxon 
matched-pairs test: Z = 3.411, p = 0.00065).  
Table 2: Mean Value on the TLKSS at different points in time 
Tegner lysholm knee scoring scale Mean Std.dev. Min Max 
Before intervention 61.9 7.4 51 74 
After 3 months 83.5 4.6 77 92 
After 6 months 83.4 4.3 75 90 
 
The difference between the mean values of 
TLKSS after 3 and 6 months was insignificant 
(Wilcoxon matched-pairs test: Z = 3.411, p = 0.00065) 
(Table 2 and Figure 7). 
 
Figure 7: Mean Age Value on the TLKSS at different points in time 
 
 
Discussion 
 
The main purpose of PRP is to restore the 
balance between protective and aggressive factors 
through anti-inflammatory effects. Abrams et al., [15] 
state that the PRP therapy for patients that have 
osteoarthritis shows positive results in both clinical 
and pre-clinical trials. In their paper, these authors 
pointed out several limits in their research because of 
the selective selection of patients. In their research on 
the quality of PRP therapy in degenerative joint 
cartilage degeneration, Campbell at al., [16] indicated 
that the International Knee Documentation Committee 
(IKDS) achieved a six-month improvement. The 
Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC), showed significant 
improvement compared to hyaluronic acid (HA) when 
it comes to pain in 3- and 6-month follow-ups. A large 
number of scientific studies have shown positive 
short-term results in the use of PRP treatment, while a 
relatively small number of studies have demonstrated 
a long-term efficacy [17]. The demographic data of 
patients such as body mass index, age and sex, play 
a role in the effectiveness of PRP [18], [19], [20]. 
Several studies have failed to confirm the use of 
medications after the PRP treatment, while some 
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studies have evaluated the effect of drugs on the 
effectiveness of PRP [21]. 
In conclusion, the application of PRP in the 
field of medicine is widely applied, and it will continue 
to be because the understanding of PRP therapy is 
increasingly refined. This study shows the effect of 
PRP in 15 patients, with a significant reduction in pain, 
following the administration of 2-3 doses of PRP 
evaluated on the TLKSS. Also, no side effects were 
observed in any of the patients that were studied. This 
therapy represents a potential and latest method in 
short-term pain reduction, but additional studies are 
needed to prove its long-term effectiveness. 
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